# Letrozole Plus Misoprostol Versus Misoprostol Alone for Treating Women With Missed Miscarriage

> **NCT07160855** · PHASE4 · RECRUITING · sponsor: **Nishtar Medical University** · enrollment: 92 (estimated)

## Conditions studied

- Miscarriage in First Trimester
- Missed Miscarriage

## Interventions

- **DRUG:** Misoprostol (given vaginally)
- **DRUG:** Letrozole 5 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07160855
- **Lead sponsor:** Nishtar Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-13
- **Primary completion:** 2025-11-12
- **Final completion:** 2025-11-12
- **Target enrollment:** 92 (ESTIMATED)
- **Last updated:** 2025-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07160855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07160855, "Letrozole Plus Misoprostol Versus Misoprostol Alone for Treating Women With Missed Miscarriage". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07160855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*